1. You Are At:
  2. English News
  3. India
  4. Transparent and based on scientific data, says Harsh Vardhan on Covishield dose gap decision

Transparent and based on scientific data, says Harsh Vardhan on Covishield dose gap decision

The government had in May increased the gap between two doses of Covishield from four-six weeks to 12-16 weeks.

India TV News Desk India TV News Desk
New Delhi Updated on: June 16, 2021 15:08 IST
covishield gap
Image Source : PTI (FILE)

Transparent and based on scientific data, says Harsh Vardhan on Covishield dose gap decision

Union Health Minister Harsh Vardhan on Wednesday said that the decision to increase the gap between two doses of the Covishield vaccine was taken in a transparent manner and based on scientific data.

"The decision to increase the gap between administering two doses of Covishield has been taken in a transparent manner based on scientific data. India has a robust mechanism to evaluate data. It is unfortunate that such an important issue is being politicised!" he tweeted and attached a statement from the government that quoted Dr NK Arora, the chairman of the National Technical Advisory Group on Immunisation (NTAGI), on the topic.

The clarification came amid reports that government increased intervals without the "support of the scientific group".

Meanwhile, Arora said that siscussions are underway on whether India should have a four or eight weeks interval for Covishield vaccine. Covishield is the local version of the Oxford-AstraZeneca vaccine. Pune-based Serum Institute of India is manufacture the druge.

He said that the emerging evidence and reports regarding efficacy of partial versus full immunisation are also under consideration.

The government had in May increased the gap between two doses of Covishield from four-six weeks to 12-16 weeks.

According to Arora, the move to increase the gap was based on scientific decision and there was no dissenting voice among the National Technical Advisory Group on Immunisation (NTAGI) members.

READ MORE: 'Twisted & misrepresented': Centre rubbishes Congress’ charge of 'calf serum used in Covaxin'

READ MORE: Twitter failed to comply with new IT rules, deliberately chose path of non-compliance: Govt

Latest India News

Write a comment

Tokyo Olympics 2020
X